Hims and Hers Spending More to Fuel Global Expansion
Hims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
When To Choose A Benchmark Over A Strategic Index explains decision points for selecting benchmarks based on goals, cost, and risk tolerance.
25,499 articlesHims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
An Oppenheimer upgrade follows Oracle’s dramatic price drop, suggesting patient investors could access a premier grow...
Investors are watching Lucid Group stock going through a period of volatility as the company navigates ramp challenge...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
JPMorgan faces renewed scrutiny as Scott Bessent challenges its research on insurance for ships transiting the Strait...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Jack Schlossberg issues a blunt warning to America’s CEOs: treat culture and AI-driven shifts as core business risks,...
A Melius analyst warns that Microsoft's Copilot leadership reshuffle may signal deeper misalignment between AI ambiti...
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
A crypto firm reaffirmed its ties to World Liberty, stating that the Trump family remains involved despite market vol...